Press Releases & Articles Search for: AllArticleNewsKinnate Biopharma Appoints Dean J. Mitchell as Chairman of the Board09/09/20 | NewsRead MoreKinnate Biopharma Closes $98 Million Series C Financing08/26/20 | NewsRead MoreKinnate Biopharma Appoints Dr. Richard Williams as Chief Medical Officer07/08/20 | NewsRead MorePrecision Oncology News: Kinnate Exiting Stealth Mode With Plans to Move Lead RAF Inhibitor Into Clinical Trials Next Year06/17/20 | ArticleRead MoreKinnate Biopharma Appoints Nima Farzan as Chief Executive Officer05/27/20 | NewsRead MoreKinnate Biopharma Closes $74.5M Series B Financing12/19/19 | NewsRead MoreFount Therapeutics Secures $22M Series A Financing04/11/18 | NewsRead More
Precision Oncology News: Kinnate Exiting Stealth Mode With Plans to Move Lead RAF Inhibitor Into Clinical Trials Next Year06/17/20 | ArticleRead More